StrataDx

What StrataDx does

StrataDx is a national anatomic pathology laboratory headquartered in Lexington, Massachusetts, providing diagnostic pathology services with a primary focus on dermatopathology and oral pathology, and secondary focus on podiatric, urologic, and general pathology. The company operates a CAP-accredited laboratory offering a comprehensive test menu including immunohistochemistry, 200+ special stains, immunofluorescence, in situ hybridization, and molecular diagnostics. Its proprietary DermSTAT Skin Infection PCR Tests and Onychodystrophy PCR Test with Terbinafine Resistance provide validated molecular diagnostics with reported sensitivity and specificity of 92-100%, outperforming conventional culture methods. The company serves dermatologists, podiatrists, oral surgeons, and dental practitioners, as well as biotechnology, pharmaceutical, academic, and government research programs through clinical research support services.

The company employs 51-100 staff including a roster of board-certified dermatopathologists and oral pathologists trained at leading institutions such as Harvard, Tufts, MD Anderson, and Memorial Sloan Kettering. Operations are supported by an in-house courier network for local specimen pickup, national FedEx/UPS partnerships for broader reach, EMR integration, and a dedicated physician services portal (LKConnect). The business generates revenue primarily through transaction-based diagnostic testing fees billed to insurance (in-network with Aetna, Cigna, Humana, UnitedHealthcare, and various state Medicaid programs) and patient payments for deductibles and co-payments, with additional revenue from per-specimen technical preparation services and clinical research engagements.

StrataDx's corporate history includes its October 2018 acquisition by the parent of Bako Diagnostics, allowing both organizations to operate under common ownership while maintaining separate clinical laboratories. In December 2025, Fulgent Genetics (NASDAQ: FLGT) announced a definitive agreement to acquire StrataDx alongside Bako Diagnostics for approximately $55.5 million; the acquisition was completed in March 2026 for approximately $56.9 million in cash. The acquired business is expected to contribute approximately $50-55 million in annual revenue to Fulgent as part of its expansion into specialty laboratory testing and transformation into a fully integrated precision medicine company.

Name

StrataDx

Legal name

Strata Pathology Services, Inc.

Website

https://stratadx.com

Company type

Private

Founded year

1984

Operating status

Acquired

Headcount range

51–100 employees

Short description

StrataDx is a national CAP-accredited anatomic pathology laboratory specializing in dermatopathology and oral pathology, serving dermatologists, podiatrists, and oral surgeons through molecular diagnostics, PCR testing, and immunohistochemistry services.

Ownership category

akta.pro rank

Product category

Diagnostic Pathology Services

NAICS

Medical Laboratories (621511)

SIC

Services-Testing Laboratories (8734)

akta.pro primary industry

Dermatopathology (HLAKACAC)

akta.pro secondary industry

Sample Logistics, Biorepository & IVD Kit Management (Trial Support) (HLAGAEAI)

Keywords

• Dermatopathology services
• Oral pathology diagnostics
• Molecular diagnostic testing
• Anatomic pathology laboratory
• PCR skin infection testing

Headquarters

HQ city

Lexington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Diagnostic Pathology Testing Services: Clinical and anatomic pathology diagnostic services including dermatopathology, oral pathology, general pathology, and specialized testing such as PCR panels, immunohistochemistry, and immunofluorescence. Revenue generated through insurance billing and patient payments for deductibles and co-payments not covered by contract.
2. Technical Preparation Services: Technical histology services for office-based and hospital-based pathology practices including H&E stained slides, special stains, and immunohistochemistry, provided on a per-specimen basis.
3. Clinical Research Support: Slide preparation and diagnostic services supporting biotechnology, pharmaceutical, academic, and government research programs.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

StrataDx is a national anatomic pathology laboratory that provides dermatopathology, oral pathology, and general/urologic pathology diagnostic services to physicians. It offers specialized molecular testing including the DermSTAT PCR skin infection panels and Onychodystrophy PCR test with terbinafine resistance detection, supported by a 200+ immunohistochemistry and special stains menu, technical preparation services, second-opinion consultations, and clinical research support for biotech and pharmaceutical clients.

Product overview

StrataDx is a national diagnostic laboratory providing a comprehensive pathology services portfolio centered on dermatopathology and oral pathology. The core offering consists of dermatopathology services for skin conditions and oral pathology services, supported by specialized testing products including DermSTAT™ Skin Infection PCR Tests for molecular diagnostics and Onychodystrophy PCR Testing with Terbinafine Resistance. Additional services encompass technical preparation (TC/PC), pathology consultations, clinical research support, and vacation coverage. The company operates as a single unified diagnostic laboratory brand rather than a platform-plus-modules architecture, with all services integrated through its CAP-accredited laboratory in Lexington, Massachusetts.

Differentiator

Problem solved

Functional benefit

Products and services

• Dermatopathology Services Diagnostic pathology services for skin conditions including melanocytic lesions, soft tissue lesions, dermatoses, and lymphomas. Provided for dermatologists and dermatology practices by board-certified dermatopathologists with expertise in inflammatory disorders and complex melanocytic lesions.
• Oral Pathology Services Comprehensive oral pathology diagnostic services for oral surgeons and dental practitioners, including biopsy interpretation and oral mucosal evaluation. Affiliated with Brigham and Women's Hospital, Harvard University School of Dental Medicine, and Boston Medical Center.
• DermSTAT Skin Infection PCR Tests Real-time PCR diagnostic panels for skin infections with next-day results, validated at 95-100% sensitivity and specificity. Panels cover bacterial (Staphylococcus aureus, Streptococcus pyogenes, mecA detection), viral (HSV-1, HSV-2, VZV), mycotic (dermatophytes, Candida, Malassezia), scabies, and web space infections. Provided for dermatologists and other physicians.
• Onychodystrophy PCR Test with Terbinafine Resistance PCR-based nail infection diagnostic that detects dermatophytes, saprophytes, yeasts, and Pseudomonas aeruginosa, with reflex terbinafine resistance detection for Trichophyton rubrum and T. mentagrophytes. Proprietary reflex algorithm detects 12 terbinafine-resistant mutations in four reactions. Provided for dermatologists and podiatrists.
• TC/PC (Technical Preparation) Technical histology slide preparation services including routine H&E staining, special stains, and immunohistochemistry, delivered on short notice for office-based and hospital-based pathology practices.
• Pathology Consultations and Second Opinions Second opinion pathology services with board-certified dermatopathologists for challenging cases, providing thorough diagnostic review for physicians seeking expert consultation on complex dermatopathology cases.
• General Pathology / Urologic Pathology Urologic pathology services including prostate biopsy diagnostics using barcode tracking, two-pathologist case review, reports with organ maps and Partin tables, and molecular studies including urine FISH and PCA3 testing.
• Clinical Research Support CAP-accredited full-service laboratory services supporting scientific research including PCR, direct immunofluorescence (DIF), immunohistochemistry (IHC), in situ hybridization (ISH), microbiology, and 200+ special stains. Provided for biotechnology, pharmaceutical, academic, and government research programs.
• Vacation Coverage Backup pathology diagnostic coverage that enables dermatologists and pathology practices to take time off while board-certified dermatopathologists provide accurate diagnoses on inflammatory disorders and complex melanocytic lesions.
• Slow MOHS Pathology services supporting Mohs micrographic surgery, with STAT diagnoses called and faxed to offices within 24 hours of receipt. CAP-approved full-service laboratory staffed around the clock.
• Test Menu (Immunohistochemistry and Special Stains) Comprehensive testing menu including immunofluorescence, immunohistochemistry, in situ hybridization, skin and nail PCR, microbiology, and 200+ special stains performed in-house.
• Alopecia Diagnostic Expertise Specialized diagnosis of all forms of alopecia using a horizontal sectioning technique for specific diagnosis, with board-certified dermatopathologists accessible to clinical teams.

Quantifiable outcome

• DermSTAT Bacterial PCR: 95-100% sensitivity and 95-100% specificity compared to 85-90% sensitivity for culture
• +4 more outcomes

Named customers7 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Bako DiagnosticscoreStrategic or Co-development Partner · 10 October 2018Bako Diagnostics, the parent company and leading U.S. podiatry-focused pathology laboratory, acquired StrataDx in October 2018. The strategic relationship allows both companies to operate more efficiently under common ownership while maintaining separate clinical laboratories and continuing to serve customers independently. The partnership expands market reach for both organizations.

Scale indicators4 records

Expansion highlights7 records

Direct peers

• Inform Diagnostics (formerly Miraca Life Sciences): Specialty anatomic pathology laboratory with strong dermatopathology franchise and subspecialty expertise. Comparable as a national dermatopathology referral lab using board-certified subspecialists and proprietary test offerings.
• Aurora Diagnostics: Multi-site anatomic pathology laboratory group providing dermatopathology and subspecialty pathology services. Directly comparable as a specialty pathology operator with hospital and dermatology group clients.
• CBLPath: Specialty anatomic and dermatopathology laboratory offering expert consultation and molecular diagnostics. Directly comparable given overlapping dermatopathology focus and similar subspecialist staffing model (a prior StrataDx pathologist worked at CBLPath).
• ProPath: Subspecialty anatomic pathology group with strong dermatopathology, oral pathology, and molecular testing offerings. Comparable as a focused specialty pathology provider serving dermatology and oral surgery practices with a similar consultative service model.
• Bako Diagnostics: Podiatric pathology specialist that was StrataDx's sister company under common ownership before the joint 2026 acquisition by Fulgent Genetics. Operates an analogous specialty pathology model targeting podiatrists and is the most direct comparator in business model and customer base.

Broad incumbents

• Sonic Healthcare USA: International reference laboratory group with U.S. anatomic pathology operations. Comparable via multi-state pathology lab footprint; a former StrataDx pathologist previously worked at Sonic Healthcare USA.
• Laboratory Corporation of America (LabCorp): Major U.S. clinical reference laboratory with anatomic and dermatopathology capabilities through its Dianon and other specialty units. Comparable as a competitor with national payer reach, though dermatopathology is not its focus.
• Quest Diagnostics: Largest U.S. reference laboratory offering dermatopathology and anatomic pathology services. Comparable via overlapping payer contracts, logistics infrastructure, and EMR integration, though dermatopathology is a small piece of a much broader menu.
• AmeriPath (Quest Diagnostics): Subspecialty anatomic pathology subsidiary of Quest Diagnostics. Comparable as a dermatopathology and oral pathology provider with national reach, but operates as part of a much broader reference lab portfolio rather than a focused niche.

Emerging players

• PathologyWatch: Digital dermatopathology platform combining AI-assisted slide analysis with subspecialty reads. Comparable to StrataDx's dermatopathology focus via technology-enabled delivery, representing the digital-native competitive threat to traditional specialty labs.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/StrataDx
• Facebookfacebook.com/stratadx
• LinkedInlinkedin.com/company/stratadiagnostics
• Instagraminstagram.com/strata_dx

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about StrataDx